BIO:ON Card News
Card news
The card news I post on Instagram (@bio.on_insight), collected in one place. Swipe through biotech and pharma stories one card at a time.
· 7 cards
Could hep B treatment end? FDA approves GSK's bepirovirsen
After a six-month course, 1 in 5 patients kept the virus undetectable off all drugs. The first antisense (ASO) drug for chronic hepatitis B is now approved in the US.
· 7 cards
Lose weight with a pill? Lilly's Foundayo gets a thumbs-up in Europe
Europe's expert panel recommended approving Lilly's once-a-day weight-loss pill Foundayo. The European Commission still has the final say.
· 7 cards
Chinese biotech: not for sale? Beijing's draft takeover ban
Beijing says foreign firms can license its biotech, but not buy it outright. It's still a draft, with comments closing on 15 November.